Abstract
Cervical carcinomas are most frequently associated with human papillomaviruses (HPV), whose E6 and E7 oncogenes products induce cellular immortalization. The papillomavirus E2 protein is a transcription factor, which represses the expression of the viral oncogenes, and activates viral DNA replication during the vegetative viral cycle. This protein is specifically inactivated in HPV18-associated carcinoma cells, suggesting that E2 functions prevent carcinogenic progression. Indeed, ectopic expression of E2 in cervical carcinoma cells strongly inhibits cell proliferation. Here we show that above a threshold level of expression, the E2 protein induces apoptosis, independently of other viral functions. The amino-terminal domain is responsible for this apoptotic activity, but surprisingly with no involvement of its transcriptional functions. The death pathway triggered by E2 relies on activation of the initiator caspase 8, specific of the extrinsic pathway of apoptosis. E2 itself is cleaved by caspases during cell death, providing an example of an apoptotic inducer that is itself a target for caspase processing. The autonomous proapoptotic activity of HPV18 E2 described here may counteract the proliferative functions of viral oncogenes, and renders the inactivation of E2 crucial for carcinogenic progression.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Antson AA, Burns JE, Moroz OV, Scott DJ, Sanders CM, Bronstein IB, Dodson GG, Wilson KS and Maitland NJ . (2000). Nature, 403, 805–809.
Ashkenazi A and Dixit VM . (1998). Science, 281, 1305–1308.
Bellanger S, Demeret C, Goyat S and Thierry F . (2001). J. Virol, 75, 7244–7251.
Corden SA, Sant-Cassia LJ, Easton AJ and Morris AG . (1999). Pathol Mol Pathol, 52, 275–282.
Crouzet J, Naudin L, Orsini C, Vigne E, Ferrero L, Le Roux A, Benoit P, Latta M, Torrent C, Branellec D, Denefle P, Mayaux JF, Perricaudet M and Yeh P . (1997). Proc Natl Acad Sci USA, 94, 1414–1419.
Darzynkiewicz Z, Robinson JP and Crissman HA . (1994). Methods in cell biology. Academic Press Inc., San Diego.
Desaintes C and Demeret C . (1996). Seminars Cancer Biol., 7, 339–347.
Desaintes C, Demeret C, Goyat S, Yaniv M and Thierry F . (1997). EMBO J, 16, 504–514.
Desaintes C, Goyat S, Garbay S, Yaniv M and Thierry F . (1999). Oncogene, 18, 4538–4545.
Dowhanick JJ, McBride AA and Howley PM . (1995). J Virol, 69, 7791–7799.
Drewett V, Devitt A, Saxton J, Portman N, Greaney P, Cheong NE, Alnemri TF, Alnemri E and Shaw PE . (2001). J Biol Chem, 276, 33444–33451.
Duensing S, Lee LY, Duensing A, Basile J, Piboonniyom S, Gonzalez S, Crum CP and Munger K . (2000). Proc Natl Acad Sci USA, 97, 10002–10007.
Goodwin EC, Yang E, Lee CJ, Lee HW, DiMaio D and Hwang ES . (2000). Proc Natl Acad Sci USA, 97, 10978–10983.
Hwang ES, Riese DJ, Settleman J, Nilson LA, Honig J, Flynn S and Di Maio D . (1993). J Virol, 67, 3720–3729.
Kiyono T, Foster SA, Koop JI, McDougall JK, Galloway DA and Klingelhutz AJ . (1998). Nature, 396, 84–88.
Klingelhutz AJ, Foster SA and McDougall JK . (1996). Nature, 380, 79–82.
Levkau B, Scatena M, Giachelli CM, Ross R and Raines EW . (1999). Nat Cell Biol, 1, 227–233.
Maitland NJ, Conway S, Wilkinson NS, Ramsdale J, Morris JR, Sanders CM, Burns JE, Stern PL and Wells M . (1998). J Pathol, 186, 275–280.
Münger K, Basile JR, Duensing S, Eichten A, Gonzalez SL, Grace M and Zacny VL . (2001). Oncogene, 20, 7888–7898.
Scheffner M, Werness BA, Huibregste JM, Levine AJ and Howley PM . (1990). Cell, 63, 1129–1136.
Thierry F, Dostatni N, Arnos F and Yaniv M . (1990). Mol Cell Biol, 10, 4431–4437.
Thierry F and Yaniv M . (1987). EMBO J, 6, 3391–3397.
Thornberry NA, Rano TA, Peterson EP, Rasper DM, Timkey T, Garcia-Calvo M, Houtzager VM, Nordstrom PA, Roy S, Vaillancourt JP, Chapman KT and Nicholson DW . (1997). J Biol Chem, 272, 17907–17911.
Webster K, Parish J, Pandya M, Stern PL, Clarke AR and Gaston K . (2000). J Biol Chem, 275, 87–94.
Weil M, Raff MC and Braga VM . (1999). Curr Biol, 9, 361–364.
Wells SI, Francis DA, Karpova AY, Dowhanick JJ, Benson JD and Howley PM . (2000). EMBO J, 19, 5762–5771.
Wolf BB and Green DR . (1999). J Biol Chem, 274, 20049–20052.
Acknowledgements
We thank Patrice Yeh for the adenovirus recombinant vector. We are grateful to Moshe Yaniv and Jonathan Weitzman for their critical reading of the manuscript. This work was supported by the ‘Association pour la recherche contre le Cancer’ (ARC).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Demeret, C., Garcia-Carranca, A. & Thierry, F. Transcription-independent triggering of the extrinsic pathway of apoptosis by human papillomavirus 18 E2 protein. Oncogene 22, 168–175 (2003). https://doi.org/10.1038/sj.onc.1206108
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1206108
Keywords
This article is cited by
-
Cell death in head and neck cancer pathogenesis and treatment
Cell Death & Disease (2021)
-
Intratype variants of the E2 protein from human papillomavirus type 18 induce different gene expression profiles associated with apoptosis and cell proliferation
Archives of Virology (2019)
-
HPV16-E2 protein modifies self-renewal and differentiation rate in progenitor cells of human immortalized keratinocytes
Virology Journal (2017)
-
Insights into the mechanism of human papillomavirus E2-induced procaspase-8 activation and cell death
Scientific Reports (2016)
-
Construction d’un vecteur d’expression chez Lactococcus lactis basée sur la production d’une protéine ancrée de Papillomavirus humain 16 E2/E7
Journal Africain du Cancer / African Journal of Cancer (2015)